Literature DB >> 21955276

Lysine demethylases inhibitors.

Takayoshi Suzuki1, Naoki Miyata.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21955276     DOI： 10.1021/jm201048w

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  46 in total

1.  Cyclopropanamine Compounds and Use Thereof.

Authors:  Benjamin Blass
Journal:  ACS Med Chem Lett       Date:  2015-12-01       Impact factor: 4.345

Review 2.  Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.

Authors:  Zhanxin Wang; Dinshaw J Patel
Journal:  Q Rev Biophys       Date:  2013-09-02       Impact factor: 5.318

3.  Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures.

Authors:  Shannon L Nowotarski; Boobalan Pachaiyappan; Steven L Holshouser; Craig J Kutz; Youxuan Li; Yi Huang; Shiv K Sharma; Robert A Casero; Patrick M Woster
Journal:  Bioorg Med Chem       Date:  2015-02-07       Impact factor: 3.641

4.  Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.

Authors:  Martin L Schmitt; Alexander-Thomas Hauser; Luca Carlino; Martin Pippel; Johannes Schulz-Fincke; Eric Metzger; Dominica Willmann; Teresa Yiu; Michelle Barton; Roland Schüle; Wolfgang Sippl; Manfred Jung
Journal:  J Med Chem       Date:  2013-09-05       Impact factor: 7.446

Review 5.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

Review 6.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

7.  3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.

Authors:  Craig J Kutz; Steven L Holshouser; Ethan A Marrow; Patrick M Woster
Journal:  Medchemcomm       Date:  2014-12       Impact factor: 3.597

Review 8.  High-throughput screening to identify inhibitors of lysine demethylases.

Authors:  Molly Gale; Qin Yan
Journal:  Epigenomics       Date:  2015       Impact factor: 4.778

9.  3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1.

Authors:  Fangrui Wu; Chao Zhou; Yuan Yao; Liping Wei; Zizhen Feng; Lisheng Deng; Yongcheng Song
Journal:  J Med Chem       Date:  2015-12-24       Impact factor: 7.446

10.  Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.

Authors:  Tae-Dong Kim; Fang Jin; Sook Shin; Sangphil Oh; Stan A Lightfoot; Joseph P Grande; Aaron J Johnson; Jan M van Deursen; Jonathan D Wren; Ralf Janknecht
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.